Gerlinger C - Search Results

1

Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.

Krempf M, Rohmer V, Farnier M, Issa-Sayegh M, Corda C, Sirugue I, Gerlinger C, Masseyeff-Elbaz MF. Krempf M, et al. Among authors: gerlinger c. Diabetes Metab. 2000 May;26(3):184-91. Diabetes Metab. 2000. PMID: 10880891 Clinical Trial.

2

Efficacy and tolerance of 200 mg micronised fenofibrate administered over a 6-month period in hyperlipidaemic patients: an open Belgian multicenter study.

Kornitzer M, Dramaix M, Vandenbroek MD, Everaert L, Gerlinger C. Kornitzer M, et al. Among authors: gerlinger c. Atherosclerosis. 1994 Oct;110 Suppl:S49-54. doi: 10.1016/0021-9150(94)05378-v. Atherosclerosis. 1994. PMID: 7857385 Clinical Trial.

3

A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.

Gaspard U, Endrikat J, Desager JP, Buicu C, Gerlinger C, Heithecker R. Gaspard U, et al. Among authors: gerlinger c. Contraception. 2004 Apr;69(4):271-8. doi: 10.1016/j.contraception.2003.11.003. Contraception. 2004. PMID: 15033400 Clinical Trial.

4

A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women.

Archer DF, Schmelter T, Schaefers M, Gerlinger C, Gude K. Archer DF, et al. Among authors: gerlinger c. Menopause. 2014 Mar;21(3):227-35. doi: 10.1097/GME.0b013e31829c1431. Menopause. 2014. PMID: 23963307 Clinical Trial.

5

A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol.

Kluft C, Endrikat J, Mulder SM, Gerlinger C, Heithecker R. Kluft C, et al. Among authors: gerlinger c. Contraception. 2006 Apr;73(4):336-43. doi: 10.1016/j.contraception.2005.09.015. Contraception. 2006. PMID: 16531162 Clinical Trial.

6

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.

Endrikat J, Düsterberg B, Ruebig A, Gerlinger C, Strowitzki T. Endrikat J, et al. Among authors: gerlinger c. Contraception. 1999 Nov;60(5):269-74. doi: 10.1016/s0010-7824(99)00097-9. Contraception. 1999. PMID: 10717778 Clinical Trial.

7

Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone.

Endrikat J, Hite R, Bannemerschult R, Gerlinger C, Schmidt W. Endrikat J, et al. Among authors: gerlinger c. Contraception. 2001 Jul;64(1):3-10. doi: 10.1016/s0010-7824(01)00221-9. Contraception. 2001. PMID: 11535206 Clinical Trial.

8

A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism.

Gaspard U, Scheen A, Endrikat J, Buicu C, Lefebvre P, Gerlinger C, Heithecker R. Gaspard U, et al. Among authors: gerlinger c. Contraception. 2003 Jun;67(6):423-9. doi: 10.1016/s0010-7824(02)00537-1. Contraception. 2003. PMID: 12814810 Free article. Clinical Trial.

9

A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight.

Endrikat J, Sandri M, Gerlinger C, Rübig A, Schmidt W, Fortier M. Endrikat J, et al. Among authors: gerlinger c. Eur J Contracept Reprod Health Care. 2007 Sep;12(3):220-8. doi: 10.1080/13625180701440818. Eur J Contracept Reprod Health Care. 2007. PMID: 17763260 Clinical Trial.

10

Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada.

Endrikat JS, Milchev NP, Kapamadzija A, Georgievska J, Gerlinger C, Schmidt W, Feroze S. Endrikat JS, et al. Among authors: gerlinger c. Contraception. 2009 Jun;79(6):428-32. doi: 10.1016/j.contraception.2008.12.007. Epub 2009 Feb 7. Contraception. 2009. PMID: 19442777 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page